Labor & Human Rights Labor & Human Rights Suppliers shall support and respect the protection of internationally proclaimed human rights.
Giving Life a Chance Giving Life a Chance The Angels initiative honours stroke units and the everyday heroes making a difference for stroke patients
Generalized pustular psoriasis: Unmet needs Generalized pustular psoriasis: Unmet needs Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the impact of living with GPP including unseen challenges and future management.
1885-1948: Innovative beginnings 1885-1948: Innovative beginnings The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products
PRRS Research Award 2022 PRRS Research Award 2022 Bridging science and veterinary practice for swine health: The winners of the European PRRS Award 2022
Neovascular AMD (wet AMD) Neovascular AMD (wet AMD) Neovascular AMD (or wet AMD) is a severe form of advanced age-related macular degeneration that can lead to irreversible vision loss if untreated
Making Every Second Count Making Every Second Count The Angels initiative honours emergency response teams making a difference for stroke patients
Nurjanahs Story Nurjanahs Story Nurjanah went from a sporty young woman to someone who no longer had the energy to do simple, everyday tasks. She was diagnosed with scleroderma.
Survodutide Phase III study weight loss Survodutide Phase III study weight loss Boehringer Ingelheim to advance survodutide into three global Phase III studies in obesity
Purpose: Finding the long-missed meaning Purpose: Finding the long-missed meaning Cancer survivor Missy Pappion is happy at Boehringer Ingelheim after climbing the corporate ladder
GPP: there is more than you see GPP: there is more than you see Generalized Pustular Psoriasis is a rare neutrophilic skin condition. Watch an animation to learn about its recurrent nature and how it affects people
CHMP_opinion_nintedanib_ILD_PF CHMP_opinion_nintedanib_ILD_PF Nintedanib received a CHMP positive opinion for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
1948-1990: Going global 1948-1990: Going global The Boehringer Ingelheim history from 1948-1990, with milestones
European Commission approves SPEVIGO® for new and expanded indications in generalized pustular psoriasis European Commission approves SPEVIGO® for new and expanded indications in generalized pustular psoriasis European Commission approves SPEVIGO® for new and expanded indications in generalized pustular psoriasis
Stargardt Disease Stargardt Disease Stargardt Disease is a hereditary condition which causes degeneration of cells in the retina at the back of the eye.
Raising Questions or Concerns Raising Questions or Concerns Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim.
Spesolimab prevents GPP flares Spesolimab prevents GPP flares Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial
Innovation in medicinal chemistry Innovation in medicinal chemistry Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
Imagine: Ecological stoves safeguard family health in Mexico Imagine: Ecological stoves safeguard family health in Mexico With Fondo Para la Paz, we’ve developed ecological stoves for safer indoor cooking, enhancing respiratory health for rural Mexican families
founding-member-of-QUTAC founding-member-of-QUTAC Together, the members of this newly founded consortium want to explore industrial applications for quantum computing
Are combination therapies the answer to battling KRAS cancers? Are combination therapies the answer to battling KRAS cancers? Dr Ulrich Dünzinger and Kristie Fernamberg talk about their work with the SOS1 KRAS inhibitor to block tumour-triggering signal
Mental health: a $1 trillion burden demanding policy action Mental health: a $1 trillion burden demanding policy action Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.
EC_approval_nintedanib_ILD_PF EC_approval_nintedanib_ILD_PF European Commission approves nintedanib for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
Geographic Atrophy Geographic Atrophy Geographic atrophy (GA) is an advanced and severe form of dry age-related macular degeneration (AMD) that progresses slowly but can lead to permanent vision loss.